Ramona Dadu

Ramona Dadu is an Assistant Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on thyroid oncology, specifically investigating targeted therapies and immunotherapies for advanced thyroid cancers, including anaplastic thyroid carcinoma and medullary thyroid carcinoma. Her recent work explores mechanisms of resistance to selective RET inhibitors, the efficacy of lenvatinib plus pembrolizumab in BRAF wild-type anaplastic thyroid cancer, and neoadjuvant pembrolizumab combined with dabrafenib and trametinib for BRAF V600E-mutated disease. She also examines cardiac dysfunction associated with BRAF and MEK inhibitors. Her publications appear in Thyroid, JCO Precision Oncology, and the Journal of Clinical Oncology.